NRX Pharmaceuticals, Inc. (NRXP)
1.86
+0.06
(+3.33%)
USD |
NASDAQ |
Mar 13, 16:00
1.84
-0.02
(-1.08%)
After-Hours: 20:00
NRX Pharmaceuticals EPS Diluted (Quarterly) : -0.2649 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Synergy CHC Corp. | 0.0124 |
| Definium Therapeutics, Inc. | -0.5106 |
| Acurx Pharmaceuticals, Inc. | -0.6722 |
| Atai Beckley, Inc. | -0.2807 |
| Alto Neuroscience, Inc. | -0.5232 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.89M |
| Revenue (Quarterly) | 0.242M |
| Total Expenses (Quarterly) | 6.132M |
| Enterprise Value | 58.29M |
| Gross Profit Margin (Quarterly) | 42.98% |
| Profit Margin (Quarterly) | -2.43K% |
| Earnings Yield | -126.6% |
| Normalized Earnings Yield | -63.89 |